School of Medicine
Showing 101-115 of 115 Results
-
Aaran Vijayakumaran
Postdoctoral Scholar, Biochemistry
BioAaran Vijayakumaran, PhD is a Postdoctoral Scholar at Stanford University School of Medicine, where he researches the cell biology of inherited Parkinson’s Disease in the Department of Biochemistry under Professor Suzanne Pfeffer.
He completed his PhD at the University of Cambridge, applying volumetric electron microscopy and deep-learning based image segmentation to generate the first nanoscale map of the human airway epithelium. His doctoral work revealed how cellular architecture and metabolism remodel during differentiation, with a particular focus on the motile cilia, their rootlets, and their structural contacts with mitochondria and the consequences for mitochondrial metabolism. Beyond research, Aaran is active in the biotech and innovation ecosystem. He was awarded a scholarship to join EnterpriseTECH at Cambridge Judge Business School, served as an Investment Fellow Intern at Syncona, and worked as a Venture Builder Intern at Cambridge Future Tech and OmniBuds, a medical device startup. In these roles, he contributed to early-stage strategy, clinical trial planning, and commercial development. -
Timothy Ting-Hsuan Wu
MD Student, expected graduation Spring 2026
Ph.D. Student in Biochemistry, admitted Summer 2021
Casual - Non-Exempt, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineCurrent Research and Scholarly InterestsMolecular and cellular basis of lung development, renewal and disease;
Single cell analysis of SARS-CoV-2 lung infection;
Vascular inflammation and immune dysregulation in pulmonary hypertension. -
Haopeng Xiao
Assistant Professor of Biochemistry
BioUnderstanding mechanisms of metabolic regulation in physiology and disease forms the basis for developing therapies to treat diseases in which metabolism is perturbed. We devise novel mass spectrometry (MS)-based proteomics technologies, combined with data science, to systematically discover mechanisms of metabolic regulation over protein function. Our strategies established the first tissue-specific landscape of protein cysteine redox regulation during aging, elucidating mechanisms of redox signaling in physiology that remained elusive for decades. We also leverage the genetic diversity of outbred populations to systematically annotate protein function and protein-metabolite co-regulation. The aim of our research program is to develop next-generation MS-based strategies to understand mechanisms of metabolic regulation in aging, metabolic disease, and cancer, and to use this knowledge as a basis to develop translational therapeutics.
